| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |